Group 1 - The company, Guoshengtang (02273.HK), announced a share buyback on October 24, 2025, spending HKD 4.1767 million to repurchase 140,600 shares at a price range of HKD 29.52 to 29.90 per share [1] - On October 23, 2025, the company also repurchased 199,000 shares for HKD 5.86 million [1]

Core Viewpoint - The company, Guoshengtang (02273), announced a share buyback plan, indicating confidence in its financial position and future prospects [1] Group 1 - The company will spend HKD 4.1767 million to repurchase 140,600 shares [1]

Core Viewpoint - The company, Gushengtang (02273), announced a share buyback plan, indicating a strategic move to enhance shareholder value through the repurchase of its own shares [1] Group 1 - The company will spend HKD 4.1767 million to repurchase 140,600 shares [1]

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) 表格類別： 股票 狀態： 新提交 公司名稱： 固生堂控股有限公司 呈交日期： 2025年10月24日 如上市發行人的已發行股份或庫存股份出現變動而須根據《香港聯合交易所有限公司（「香港聯交所」）證券上市規則》(「《主板上市規則》」)第13.25A條 / 《香港聯合交易所有限公司GEM證券 上市規則》(「《GEM上市規則》」)第17.27A條作出披露，必須填妥第一章節 。 | 第一章節 | | | | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | | 於香港聯交所上市 | 是 | | | | 證券代號 (如上市) | 02273 | 說明 | | | | | | | | | A. 已發行股份或庫存股份變動 | | | | | | | | | | | | | | 已發行股份（不包括庫存股份）變動 | | | 庫存股份變動 | | | | | ...

Major Events - Minglue Technology (02718) plans to offer 7.219 million Class A shares globally from October 23 to October 28, with cornerstone subscriptions amounting to $59 million [1] - Wisco Properties (00230) received a privatization offer from Wisco Hong Kong at a premium of approximately 104.08%, with trading resuming on October 24 [1] - Junyu Foundation (01757) was acquired by China Venture Capital Holdings for 75% of its shares at a discount of about 79.06%, with trading resuming on October 24 [1] - Kangda Foods (00834) was acquired by Gaosi Shi for approximately 54.69% of the company’s shares at a premium of about 16.23%, with trading resuming on October 24 [1] - Hutchison China MediTech (00013) presented data on HMPL-A251 at the AACR-NCI-EORTC International Conference on Molecular Targeted and Cancer Therapeutics [1] - Giant Bio (02367) received a medical device registration certificate for its Type I α1 collagen lyophilized fiber product [1] - Yiming Anke-B (01541) completed the first patient dosing in the Phase IB/II clinical trial of IMM2510 combined with IMM01 [1] - Heng Rui Medicine (01276) received approval to conduct clinical trials for injection of Rikan Trastuzumab [1] - Hansoh Pharmaceutical (03692) had its application for HS-10365 capsule marketing approval accepted by the National Medical Products Administration [1] - Baixin An-B (02185) completed market access and the first commercial surgery for the IBERIS® RDN system in Switzerland [1] - Haotian International Construction Investment (01341) purchased a total of 646 units of Ethereum as of October 23 [1] Share Buybacks/Reductions - Cornerstone Pharmaceuticals-B (02616) saw CEO Yang Jianxin and senior management purchase an additional 1 million shares [2] - Midea Group (00300) repurchased 1.3434 million A shares for approximately 99.998 million yuan on October 23 [2] - China Communications Construction (01800) repurchased 119.45 million A shares for approximately 10.5994 million yuan on October 23 [2] - Mengniu Dairy (02319) repurchased 700,000 shares for approximately 10.0692 million HKD on October 23 [2] - Lianlian Digital (02598) spent about 7.5555 million HKD to repurchase 967,000 shares on October 23 [2] - Lianyi Rong Technology-W (09959) repurchased 2.47 million shares for approximately 7.4137 million HKD on October 23 [2] - Heng Rui Medicine (01276) repurchased 97,500 A shares for approximately 6.2808 million yuan on October 23 [2] - Gushengtang (02273) repurchased 19,860 shares for approximately 5.8634 million HKD on October 23 [2] Operating Performance - Ping An Good Doctor (01833) reported total revenue of approximately 3.725 billion yuan for the first three quarters, a year-on-year increase of 13.6%, and plans to continue expanding AI technology to enhance medical service efficiency and quality [2] - Sands China Ltd. (01928) reported a 7.5% year-on-year increase in net revenue to $1.9 billion for the third quarter [2] - Livzon Pharmaceutical (01513) announced a net profit attributable to shareholders of 1.754 billion yuan for the first three quarters, a year-on-year increase of 4.86% [2] - China Railway Construction (01186) signed new contracts totaling 1.518765 trillion yuan in the first three quarters, a year-on-year increase of 3.08% [2] - Prada (01913) reported net revenue of 4.07 billion euros for the first three quarters, a year-on-year increase of 9% [2] Additional Performance Metrics - Baio Family Interactive (02100) reported 10.2 million active accounts in the third quarter, a year-on-year increase of 37.8% [3] - Anton Oilfield Services (03337) secured new orders worth 1.273 billion yuan in the third quarter [3]

Core Points - The company Gushengtang has been actively repurchasing its shares, with a total of 482,530 shares bought back since September 10, amounting to HKD 151 million [2][3] - The stock price has seen a decline of 11.02% during the repurchase period, with the latest closing price at HKD 29.620, down 1.73% on the day of the latest buyback [2][3] - Year-to-date, Gushengtang has conducted 53 repurchase transactions, totaling 777,990 shares and an expenditure of HKD 245 million [2][3] Repurchase Details - On October 23, Gushengtang repurchased 198,600 shares at a price range of HKD 29.240 to HKD 29.800, with a total expenditure of HKD 5.8634 million [2] - The highest repurchase price during the recent buyback was HKD 30.200 on October 22, while the lowest was HKD 29.240 on October 23 [2] - The company has consistently repurchased shares over the past 30 days, indicating a strong commitment to supporting its stock price [2][3]

固生堂(02273)发布公告，于2025年10月23日，该公司斥资586.34万港元回购19.86万股。 ...

Group 1 - The company, Guoshengtang (02273.HK), announced a share buyback plan to repurchase 199,000 shares at a total cost of HKD 5.86 million [1] - The buyback will occur on October 23, 2025, with the repurchase price ranging from HKD 29.24 to HKD 29.80 per share [1]

智通财经APP讯，固生堂(02273)发布公告，于2025年10月23日，该公司斥资586.34万港元回购19.86万 股。 ...

FF305 翌日披露報表 (股份發行人 ── 已發行股份或庫存股份變動、股份購回及/或在場内出售庫存股份) FF305 | 13). | 購回股份（擬註銷但尚未註銷） | | 240,000 | 0.1017 % | HKD | 31.7036 | | --- | --- | --- | --- | --- | --- | --- | | | 變動日期 | 2025年9月23日 | | | | | | 14). | 購回股份（擬註銷但尚未註銷） | | 150,000 | 0.0636 % | HKD | 31.3359 | | | 變動日期 | 2025年9月24日 | | | | | | 15). | 購回股份（擬註銷但尚未註銷） | | 140,000 | 0.0593 % | HKD | 31.2967 | | | 變動日期 | 2025年9月25日 | | | | | | 16). | 購回股份（擬註銷但尚未註銷） | | 100,000 | 0.0424 % | HKD | 30.6404 | | | 變動日期 | 2025年9月26日 | | | | | | 17). | 購回股份（擬註銷但尚未 ...